A Phase 3 Study of Pembrolizumab in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line treatment of Participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

  • Briggs, Peter (Primary Chief Investigator (PCI))
  • Parakh, Sagun (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date20/11/19 → 24/06/20

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • lung cancer